21-101
Showing 1 - 25 of >10,000
Advanced Cancer Trial in Oxford (CXD101)
Active, not recruiting
- Advanced Cancer
-
Oxford, Oxfordshire, United KingdomOxford University Hospitals NHS Trust
Jan 6, 2022
Primary Sclerosing Cholangitis Trial in Germany, Israel, United Kingdom (CM-101, Placebo)
Recruiting
- Primary Sclerosing Cholangitis
- CM-101
- Placebo
-
Bonn, Germany
- +20 more
Sep 1, 2021
Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)
Suspended
- Metastatic Breast Cancer
- metastatic lesion biopsy
-
Brussels, Belgium
- +59 more
Jan 17, 2023
Spinal Muscular Atrophy Trial in Worldwide (OAV101)
Active, not recruiting
- Spinal Muscular Atrophy
- OAV101
-
Boston, Massachusetts
- +12 more
Jan 17, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),
Recruiting
- Solid Tumor, Adult
- +19 more
- SNS-101 (anti-VISTA)
- Cemiplimab
-
Irving, Texas
- +2 more
May 24, 2023
Smoking Cessation, Nicotine Dependence Trial in Gières (NFL-101, Placebo)
Completed
- Smoking Cessation
- Nicotine Dependence
- NFL-101
- Placebo
-
Gières, Isère, FranceEurofins Optimed
Oct 18, 2023
Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)
Recruiting
- Leiomyosarcoma
- Liposarcoma
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Celiac Disease Trial in Saint Paul, Columbus (Cohort 1 in Part A, Cohort 2 in Part A, Cohort 3 in Part A)
Recruiting
- Celiac Disease
- Cohort 1 in Part A
- +6 more
-
Saint Paul, Minnesota
- +1 more
Jan 19, 2023
EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell
Not yet recruiting
- EBV-associated Lymphomas
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
May 31, 2023
Systemic Lupus Erythematosus, SLE, Lupus Trial in United States (JBT-101, Placebo)
Completed
- Systemic Lupus Erythematosus
- +2 more
- JBT-101
- Placebo
-
La Jolla, California
- +15 more
Oct 27, 2022
Campylobacter Infections Trial in Baltimore (LMN-101, Placebo)
Completed
- Campylobacter Infections
- LMN-101
- Placebo
-
Baltimore, MarylandPharmaron
Nov 15, 2022
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated
Recruiting
- Ovarian Cancer
- +3 more
- ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
-
Blacktown, New South Wales, Australia
- +5 more
Nov 9, 2022
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)
Active, not recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Active
- ARQ-151 Vehicle
-
Montgomery, Alabama
- +48 more
Aug 10, 2022
Obesity Trial in San Diego (ARD-101, Placebo)
Completed
- Obesity
- ARD-101
- Placebo
-
San Diego, CaliforniaAltman Clinical and Translational Research Institute, University
Jan 12, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 20, 2022
Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)
Enrolling by invitation
- Idiopathic Hypersomnia
- Excessive Daytime Sleepiness
-
Peoria, Arizona
- +57 more
Nov 10, 2022